It is known that diphtheria antitoxin is associated in horse serum with its pseudoglobulin constituent. For therapeutic purposes this protein fraction has been extracted from the whole serum, thus obtaining a purer, or refined antitoxin preparation. It seemed possible that the same principle might be applied to the coagulative factor in serum, and that in this respect the active substance might likewise be linked with one protein fraction rather than with the serum as a whole. Horse serum is extensively used for hemostatic purposes, and if the coagulative principle could be separated, it might lead to the preparation of a refined hemostatic as potent as the original serum and containing a greatly diminished amount of protein.
the pseudoglobulin, after which enough is added to the filtrate to precipitate all the albumin.2 Tests with Human Serum.
The nature of the tests and their results are shown in the tables. For the test illustrated in Table I , the fractions were prepared from human serum. It was determined in the course of later tests that the fractions had apparently identical action whether prepared from human, from horse, or from sheep serum; accordingly horse serum was used as it was most available. In view of the fact that it had been found that antitoxin is associated with the pseudoglobulin in the horse, but with the globulin in the serum of the goat, it was deemed advisable to carry out the preliminary tests upon human as well as upon animal sera.' It will be noted from Table I that the addition of one or two drops of euglobulin hastened coagulation, whereas the same amount of the other proteins failed to bring about this result. This was the usual course of all experiments of this kind, although in some instances the differences did not stand out so sharply. Table II illustrates a similar test carried out in a case of hereditary hemophilia, where the blood had a coagulation time of 42 minutes and the plasma of 26 minutes. 4 Here again the euglobulin caused a marked shortening of the coagulation time, whereas the other fractions produced this effect to a less degree.
When it was not desired to obtain the three protein fractions separately but only to precipitate the euglobulin from the serum, sodium chloride was employed instead of ammonium sulphate, as the former process is simpler and was found to give an equally effective product. The method pursued was as follows: The serum was saturated in the cold with chemically pure crystals of sodium chloride. It was then filtered, and a small amount of chloroform added to the precipitate, which was dialyzed for about a week. The dialysate was taken up with Ringer's solution, and 0.3 per cent of tricresol added. This was then filtered through a Berkefeld filter and bottled in 20 cc. vials.
The percentage of total solids, which may be regarded as euglobulin, varied in the different lots prepared, so that an estimation was made in every instance. In the lot used in the test shown in Table  III , there was 2.5 per cent euglobulin, in another the percentage might be over 3 per cent, in which event it was diluted with Ringer's solution to 2 per cent. This test (Table III) shows that when we reach a certain maximum, the addition of a large amount of euglobulin ceases to have any further effect; that, for example, the coagulation time may remain the same whether we add a drop of a 1.25 per cent solution or of a 2.5 per cent solution of euglobulin to five drops of plasma. In another test (Table IV) made with a different preparation we note that two drops are more effective than one, but that we have then reached the optimal strength, and that three drops of euglobulin fail to heighten the effect. Table III likewise illustrates the fact that the euglobulin is able to hasten the clotting of plasma in purpura, another type of hemorrhagic disease. In this instance the blood was from a case of purpura showing all the usual symptoms-a slightly delayed coagulation time, a markedly diminished platelet count, a prolonged bleeding time, and a positive capillary resistance test.
Mode of Action of Euglobulin.
There are many ways in which substances exert a coagulative effect upon the blood. Without entering in detail upon this subject, it may be stated that we may divide these acceleratory substances into two groups; those which act by neutralizing inhibiting substances, and those which possess inherent activity in themselves.
To which class does euglobulin belong? The answer to this question can best be given by comparing the euglobulin to a substance which is known to derive its potency through overcoming the antithrombin of the blood. An experiment of this kind is reproduced in Table V , where the effect of tissue juice is compared with that of euglobulin. * Hirudin in these tests refers to a 1: 5,000 solution. This strength was found optimal for this experiment.
It has long been known that the various tissue juices of the body, those of the muscles, of the brain, of the glandular organs, etc., are powerful coagulants. It has also been established that they possess this power in virtue of being able to counteract the normal antithrombin of the blood. In this test thromboplastin was employed, which consists of a solution and suspension of brain, and has been described elsewhere 5 as possessing marked coagulative power both in vitro and in its clinical application. In the first part of this table we see what might be termed a state of equilibrium between the two coagulants, a parallel test in which one drop of euglobulin and one drop of a dilution of thromboplastin (1: 2,500) hasten coagulation to the same degree. When, however, an antithrombic substance, a dilute solution of hirudin, is also added to the plasma, we note (Table  V) a marked difference in action. The tissue juice almost completely neutralizes the hirudin, whereas the euglobulin is able only partly to overcome its inhibitory effect. It is evident therefore that these substances act in different ways, and that the euglobulin does not owe its power to a counteraction of the antithrombin. It is impossible to proceed further in this discussion, and to state the exact mode of action of euglobulin, as so many factors remain unknown as to the mechanism of coagulation. It would seem, however, in view of the fact that euglobulin is found in the normal blood, that it should be regarded as a physiologic coagulant, and its mode of action in these tests as merely an intensification of the normal clotting processes. In this connection we may add that this coagulative property is not common to globulins in general. For example, egg globulin showed no coagulative power (Table VI) ; and edestin, a vegetable Assn., 1915 Assn., , lxiv, 1395 globulin, when tested in various concentrations was found also to be completely devoid of activity. These negative results with ovoglobulin furthermore give evidence that the more rapid clotting, brought about by euglobulin, cannot be attributed to an increase in viscosity.
SUMMARY AND CONCLUSIONS.
The fact that the coagulative principle is closely associated with the euglobulin fraction of the blood is of clinical as well as of theoretical interest. It enables us to prepare a hemostatic containing about 2 per cent of protein which is more potent than the whole serum containing 6 to 7 per cent of protein. A preparation of this kind has been made in this laboratory from horse serum and employed during the past few months in numerous cases of bleeding. This euglobulin is absolutely sterile, as it has been passed through a Berkefeld filter, and is safeguarded against decomposition by the addition of 0.3 per cent tricresol. A detailed account of the therapeutic use of euglobulin will be reported elsewhere. It may be stated, however, that it has been employed in the various manifestations of intractable hemorrhage in which horse serum has been so largely resorted to of late years, and that in certain cases has seemed to bring about most satisfactory results; in no instance has there been any untoward effect. When intravenous injections are resorted to, euglobulin seems to be preferable to serum which contains fully three times the quantity of protein. 6 It also seems to be absorbed more quickly from the subcutaneous tissues. In all probability it will be found to meet the same indications as whole serum, possessing the advantages of concentration, and necessitating the introduction into the body of a much smaller amount of foreign protein.
